U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
DOCARAVIMAB
INN  
Official Name English
Docaravimab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G2B-KAPPA, ANTI-(RABIES VIRUS STRAINERA (EVELYN-ROCKITNIKI-ABELSETH) GLYCOPROTEIN ECTODOMAIN EPITOPE G-III), MUS MUSCULUS MONOCLONAL ANTIBODY
Common Name English
IMMUNOGLOBULIN G2B, ANTI-(RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-III) (MUS MUSCULUS MONOCLONAL 62-71-3 .GAMMA.2B-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL 62-71-3 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G2, ANTI-(RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-III) (MUS MUSCULUS MONOCLONAL .GAMMA.2-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL .KAPPA.-CHAIN, DIMER
Common Name English
62-71-3
Code English
docaravimab [INN]
Common Name English
Code System Code Type Description
INN
11198
Created by admin on Sat Dec 16 15:25:27 GMT 2023 , Edited by admin on Sat Dec 16 15:25:27 GMT 2023
PRIMARY
FDA UNII
I0HK032RR6
Created by admin on Sat Dec 16 15:25:27 GMT 2023 , Edited by admin on Sat Dec 16 15:25:27 GMT 2023
PRIMARY
NCI_THESAURUS
C175773
Created by admin on Sat Dec 16 15:25:27 GMT 2023 , Edited by admin on Sat Dec 16 15:25:27 GMT 2023
PRIMARY
CAS
2247196-23-0
Created by admin on Sat Dec 16 15:25:27 GMT 2023 , Edited by admin on Sat Dec 16 15:25:27 GMT 2023
PRIMARY
ACTIVE MOIETY
DOCARAVIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966